BIOEMTECH is a Greek SME in the field of biomedical engineering, bridging the gap between ex vivo studies and in vivo molecular imaging. The company develops benchtop molecular imaging systems and provides imaging services for the preclinical evaluation of nanoparticles and other novel radiopharmaceuticals. In addition, BIOEMTECH offers unique expertise in terms of advanced Monte Carlo simulations, Artificial Intelligence techniques and exploitation of computational models for medical imaging and dosimetry applications. BIOEMTECH consists of a multidisciplinary team with a strong background in biomedical engineering, medical physics, bioinformatics, radiochemistry, biology and nanomedicine.